Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Exchange Rate Effect (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Exchange Rate Effect for 11 consecutive years, with $23.2 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 144.79% to $23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.0 million through Dec 2025, up 216.09% year-over-year, with the annual reading at $60.0 million for FY2025, 216.09% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $23.2 million at BeOne Medicines, up from $9.9 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $64.5 million in Q4 2022, with the low at -$80.2 million in Q2 2022.
  • Average Exchange Rate Effect over 5 years is -$2.8 million, with a median of $5.4 million recorded in 2021.
  • The sharpest move saw Exchange Rate Effect plummeted 4247.95% in 2022, then surged 5299.62% in 2024.
  • Over 5 years, Exchange Rate Effect stood at $7.3 million in 2021, then surged by 788.33% to $64.5 million in 2022, then tumbled by 34.52% to $42.3 million in 2023, then plummeted by 222.35% to -$51.7 million in 2024, then skyrocketed by 144.79% to $23.2 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $23.2 million, $9.9 million, and $23.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.